Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as “customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient.
Animal drug shortages are becoming more common and this is unfortunately predicted to worsen in the years ahead, as per official reports published by veterinarians. This shortage encourages the use of widely available compounded drugs to treat a number of animal diseases. A few critical animal drug shortages highlighted by the U.S. FDA are Flunixine Injectable, 35% Perox-Aid, and Epinephrine. To make medical therapy suitable for animal requirements, compounded drugs with the desired active ingredients are unavailable. For e.g., no FDA approved drug for treating megacolon in cats is currently available in the animal drug compounding market. The only safe and effective therapy to treat chronic cat constipation was removed from the U.S. nearly two decades ago. That is why compounding drugs are the only option for veterinarians to treat animals that need pro-kinetic drug therapy.
Market Analysis and Insights: Global Animal Drug Compounding Market
The global Animal Drug Compounding market was valued at US$ 896.5 in 2020 and will reach US$ 1286.2 million by the end of 2027, growing at a CAGR of 6.2% during 2022-2027.
Global Animal Drug Compounding Scope and Market Size
The global Animal Drug Compounding market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Animal Drug Compounding market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Anti-Infective Agents
Hormones and Substitutes
Anti-Inflammatory Agents
Others
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Diagnostic Centers
The Animal Drug Compounding market is analysed and market size information is provided by regions (countries). Segment by Application, the Animal Drug Compounding market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Triangle Compounding Pharmacy
Lorraine's Pharmacy
Medisca
Diamondback Drugs
ESSENTIAL PHARMACY COMPOUNDING VET
Animal drug shortages are becoming more common and this is unfortunately predicted to worsen in the years ahead, as per official reports published by veterinarians. This shortage encourages the use of widely available compounded drugs to treat a number of animal diseases. A few critical animal drug shortages highlighted by the U.S. FDA are Flunixine Injectable, 35% Perox-Aid, and Epinephrine. To make medical therapy suitable for animal requirements, compounded drugs with the desired active ingredients are unavailable. For e.g., no FDA approved drug for treating megacolon in cats is currently available in the animal drug compounding market. The only safe and effective therapy to treat chronic cat constipation was removed from the U.S. nearly two decades ago. That is why compounding drugs are the only option for veterinarians to treat animals that need pro-kinetic drug therapy.
Market Analysis and Insights: Global Animal Drug Compounding Market
The global Animal Drug Compounding market was valued at US$ 896.5 in 2020 and will reach US$ 1286.2 million by the end of 2027, growing at a CAGR of 6.2% during 2022-2027.
Global Animal Drug Compounding Scope and Market Size
The global Animal Drug Compounding market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Animal Drug Compounding market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Anti-Infective Agents
Hormones and Substitutes
Anti-Inflammatory Agents
Others
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Diagnostic Centers
The Animal Drug Compounding market is analysed and market size information is provided by regions (countries). Segment by Application, the Animal Drug Compounding market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Triangle Compounding Pharmacy
Lorraine's Pharmacy
Medisca
Diamondback Drugs
ESSENTIAL PHARMACY COMPOUNDING VET
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
